Related Experiment Video

Updated: Jul 15, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

The elusive search for a viral culprit in non-EBV-associated Hodgkin lymphoma

Ora Paltiel1

  • 1Department of Hematology, School of Public Health, Hadassah-Hebrew University, Jerusalem 91120, Israel. ora@vms.huji.ac.il

Leukemia & Lymphoma
|April 25, 2007
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Related Experiment Videos

Last Updated: Jul 15, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

Articles linked to this work by shared authors, journal, and citation graph.

Acute maternal stress in pregnancy and cardiovascular risk factors in adolescent offspring: a birth-cohort study.

International journal of epidemiology·2026

Schizophrenia in Offspring of Holocaust Survivors: Intergenerational Effects of Preconception Parental Trauma Within the Jerusalem Perinatal Study.

The American journal of psychiatry·2026

Near-infrared OCT imaging for the assessment of anisocoria.

Eye (London, England)·2026

Pathways-to-Care Analysis of Non-Hodgkin Lymphoma in Ethiopia: A Mixed-Methods Study.

JCO global oncology·2026

Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study.

The Lancet. Infectious diseases·2025

Occupational, Lifestyle, and Medical Risk Factors for Non-Hodgkin Lymphoma: A Case-Control Study in Ethiopia.

Cancers·2025

Clinical outcomes with azole and other CYP3A4 inhibitor coadministration during venetoclax plus azacitidine or decitabine therapy in newly diagnosed acute myeloid leukemia: a systematic review and meta-analysis.

Leukemia & lymphoma·2026

Navitoclax monotherapy or in combination with ruxolitinib in patients with JAK2 inhibitor-treated myelofibrosis: results from the phase 2 REFINE and phase 3 TRANSFORM-2 studies.

Leukemia & lymphoma·2026

Evaluating YouTube videos for Hodgkin lymphoma patient education.

Leukemia & lymphoma·2026

Venetoclax consolidation deepens response and enables measurable residual disease-guided finite therapy in BTK inhibitor-treated chronic lymphocytic leukemia.

Leukemia & lymphoma·2026

Clinical outcomes of adults with PAX5-mutated or rearranged B-cell acute lymphoblastic leukemia.

Leukemia & lymphoma·2026

Efficacy and safety of three-drug induction-based MASPORE 2003 chemotherapy protocol in standard- and intermediate-risk pediatric acute lymphoblastic leukemia: a decade-long single-center experience from India.

Leukemia & lymphoma·2026

Autoantibodies neutralizing type I interferons in older twin pairs: Low concordance.

Journal of human immunity·2026

A Phase 2b Randomized Trial of Belimumab to Reduce Atherogenic Autoantibodies in COPD Patients.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026

Recent Advances in Stimuli Responsive In-Situ Gelling System for the Management of Rheumatoid Arthritis.

Recent advances in drug delivery and formulation·2026

Integrated Proteomic and Phosphoproteomic Profiling Reveals Dysregulated Inflammatory Signaling Networks in Rheumatoid Arthritis.

Omics : a journal of integrative biology·2026

Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review).

International journal of molecular medicine·2026

Jejunal Leiomyoma Arising in a Diverticulum Mimicking a Hollow Viscus Perforation: A Diagnostic Challenge.

Cureus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us